NRC Correction to Its FY 2026 Medical License Fees Repeats the Same Dollar Amounts
ANALYSIS · October 19, 2026
Slug: fee-schedules-fee-recovery-fiscal-year-2026
Package note: This Analysis covers a Nuclear Regulatory Commission correction published in the Federal Register on October 19, 2026 (91 FR 65941, FR Doc. C1-2026-12067, docket NRC-2023-0212). It amends entry 7.C in Table 2 to paragraph (d) of 10 CFR 171.16, the annual-fee table, in the NRC’s FY 2026 fee rule. That rule was published June 16, 2026, at 91 FR 36470–36509 and took effect August 17, 2026. We compared the correction line by line with the June rule text on federalregister.gov.
Primary sources
- Federal Register, “Fee Schedules; Fee Recovery for Fiscal Year 2026,” correction (October 19, 2026), 91 FR 65941: https://www.federalregister.gov/documents/2026/10/19/C1-2026-12067/fee-schedules-fee-recovery-for-fiscal-year-2026
- Federal Register, “Fee Schedules; Fee Recovery for Fiscal Year 2026,” final rule (June 16, 2026), 91 FR 36470: https://www.federalregister.gov/documents/2026/06/16/2026-12067/fee-schedules-fee-recovery-for-fiscal-year-2026
Category 7.C covers “other licenses issued under parts 30, 35, 40, and 70” for human use of byproduct, source or special nuclear material. That excludes sealed sources in teletherapy devices. In practice it covers most medical-use materials licenses, priced by number of locations of use. The correction reprints all three tiers of 7.C. It lists $23,300 for 1–5 locations and $33,000 for 6–20 locations. For more than 20 locations, the correction prints the category text and program codes but no dollar amount. The June rule sets that tier at $42,300.
Core Tension
The correction doesn’t change any fee. The $23,300 and $33,000 figures are the same ones the June rule already set for these tiers. The only difference we found between the two texts is in the 1–5 location tier: the correction adds footnote 19 to it, matching the other two tiers. Footnote 19 says licensees paying broad-scope medical fees under 7.B, 7.B.1 or 7.B.2 “are not subject to paying fees under 7.C., 7.C.1, or 7.C.2” for human-use licenses authorized on the same license. That makes the double-billing exemption apply to the smallest tier as well. The notice doesn’t say what the error was. Its page citation is also wrong: it points to “pages 6504 and 6505” of a rule that runs from page 36470 to 36509. In the June rule, entry 7.C appears on pages 36507–36508.
What the correction does
| Element | Correction text / effect |
|---|---|
| Agency | Nuclear Regulatory Commission |
| Citation | 91 FR 65941; FR Doc. C1-2026-12067; filed October 16, 2026; billing code 1505-01-D |
| Document corrected | Rule document 2026-12067, “beginning on page 36470,” June 16, 2026 |
| Location cited | “pages 6504 and 6505” (as printed; the June rule’s 7.C entries are on pages 36507–36508) |
| Provision | 10 CFR 171.16, Table 2 to paragraph (d), category 7.C |
| 7.C, 1–5 locations | $23,300, the same as the June rule; footnotes now read 9, 17 and 19 (June: 9 and 17) |
| 7.C(1), 6–20 locations | $33,000, the same as the June rule |
| 7.C(2), more than 20 locations | No dollar amount printed; the June rule lists $42,300 |
| Program codes | Same as the June rule for all three tiers |
Stated vs. claimed
| Claim | Assessment | Basis |
|---|---|---|
| The notice corrects entry 7.C of the FY 2026 annual-fee table | Verified | Correction text |
| The correction changes the fees for these medical licenses | Not supported | $23,300 and $33,000 match the June rule; no new amount for the >20 tier |
| The fee for more than 20 locations is $42,300 | Verified, from the June rule | 91 FR 36508; the correction prints no figure for this tier |
| The visible change is footnote 19 on the 1–5 tier | Verified by text comparison | The June rule lists footnotes 9 and 17 only for that tier |
| The correction’s page citation is accurate | No | The pages cited don’t exist in a rule printed at 36470–36509 |
Context / what to watch
- The >20-locations tier: Whether NRC issues a further notice. Leaving the dollar figure out of the corrected text could be read as removing it, but the notice doesn’t say it changes that fee.
- Billing: Whether FY 2026 invoices for 7.B licensees who also hold small-site 7.C authorizations show the footnote 19 exemption.
- The eCFR: Whether the codified text of 10 CFR 171.16 changes after this notice.
Publish-ready ANALYSIS · written by KVOp from the Federal Register correction and June 16 rule · 2026-10-19 · for /analysis/fee-schedules-fee-recovery-fiscal-year-2026